NextGen Healthcare Stock Forecast, Price & News

NextGen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

Is NextGen Healthcare a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NextGen Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares.
View analyst ratings for NextGen Healthcare or view top-rated stocks.

How has NextGen Healthcare's stock price been impacted by Coronavirus (COVID-19)?

NextGen Healthcare's stock was trading at $11.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NXGN stock has increased by 65.7% and is now trading at $18.24.
View which stocks have been most impacted by COVID-19.

When is NextGen Healthcare's next earnings date?

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, May 25th 2022.
View our earnings forecast for NextGen Healthcare.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) released its earnings results on Tuesday, January, 25th. The company reported $0.24 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.21 by $0.03. The company had revenue of $149.72 million for the quarter, compared to analysts' expectations of $146.32 million. NextGen Healthcare had a negative net margin of 0.69% and a positive trailing twelve-month return on equity of 12.59%. The company's revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.17 EPS.
View NextGen Healthcare's earnings history.

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare issued an update on its FY22 earnings guidance on Tuesday, January, 25th. The company provided earnings per share guidance of $0.96-1.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.95. The company issued revenue guidance of $591-595 million, compared to the consensus revenue estimate of $588.23 million.

What price target have analysts set for NXGN?

8 brokers have issued 1-year target prices for NextGen Healthcare's stock. Their forecasts range from $18.00 to $24.00. On average, they expect NextGen Healthcare's share price to reach $20.86 in the next year. This suggests a possible upside of 14.3% from the stock's current price.
View analysts' price targets for NextGen Healthcare or view top-rated stocks among Wall Street analysts.

Who are NextGen Healthcare's key executives?

NextGen Healthcare's management team includes the following people:

• David William Sides, President, Chief Executive Officer & Director (LinkedIn Profile)
• L. Allen Plunk, Executive Vice President-Operations
• James R. Arnold, Chief Financial Officer & Executive Vice President
• Robert L. Murry, Chief Medical Officer
• David A. Metcalfe, Chief Technology Officer & Executive VP

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare CEO Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among NextGen Healthcare's employees.

Who are some of NextGen Healthcare's key competitors?

Some companies that are related to NextGen Healthcare include Science Applications International (SAIC), TuSimple (TSP), Verint Systems (VRNT), Parsons (PSN), Aurora Innovation (AUR), Allscripts Healthcare Solutions (MDRX), NetScout Systems (NTCT), IonQ (IONQ), TDCX (TDCX), Unisys (UIS), Ebix (EBIX), Agilysys (AGYS), Simulations Plus (SLP), Telos (TLS) and OneSpan (OSPN).
View all of NXGN's competitors.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Smith Graham & Co. Investment Advisors LP (1.06%), AMH Equity Ltd (0.22%), Russell Investments Group Ltd. (0.18%), Strs Ohio (0.08%), State of Alaska Department of Revenue (0.06%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own NextGen Healthcare stock include Craig A Barbarosh, David Ahmadzai, David William Sides, George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends for NextGen Healthcare.

Which major investors are selling NextGen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, Russell Investments Group Ltd., Strs Ohio, Diversified Trust Co, Wedge Capital Management L L P NC, and State of Alaska Department of Revenue. Company insiders that have sold NextGen Healthcare company stock in the last year include Craig A Barbarosh, David Ahmadzai, John R Frantz, Lance Rosenzweig, and Mitchell Waters.
View insider buying and selling activity for NextGen Healthcare or view top insider-selling stocks.

Which major investors are buying NextGen Healthcare stock?

NXGN stock was bought by a variety of institutional investors in the last quarter, including AMH Equity Ltd, IFP Advisors Inc, and Louisiana State Employees Retirement System. Company insiders that have bought NextGen Healthcare stock in the last two years include David William Sides, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, Sean Brynjelsen, and Srinivas S Velamoor.
View insider buying and selling activity for NextGen Healthcare or or view top insider-buying stocks.

How do I buy shares of NextGen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $18.24.

How much money does NextGen Healthcare make?

NextGen Healthcare has a market capitalization of $1.25 billion and generates $556.82 million in revenue each year. The company earns $9.52 million in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does NextGen Healthcare have?

NextGen Healthcare employs 2,564 workers across the globe.

What is NextGen Healthcare's official website?

The official website for NextGen Healthcare is www.nextgen.com.

Where are NextGen Healthcare's headquarters?

NextGen Healthcare is headquartered at 18111 Von Karman Avenue Suite 800, Irvine CA, 92612.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at (404) 467-1500, via email at [email protected], or via fax at 949-255-2605.